Predictors of Microvascular Reperfusion After Myocardial Infarction (original) (raw)
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2015 update. A report from the American Heart Association. Circulation. 2015;131:29–322. Google Scholar
Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39:119–77. ArticlePubMed Google Scholar
Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2016;133:1135–47. ArticlePubMed Google Scholar
Menees DS, Peterson ED, Wang Y, Curtis JP, Messenger JC, Rumsfeld JS, et al. Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med. 2013;369:901–9. ArticleCASPubMed Google Scholar
Chen J, Hsieh AF-C, Dharmarajan K, Masoudi FA, Krumholz HM. National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998–2010. Circulation. 2013;128:2577–84. ArticlePubMedPubMed Central Google Scholar
Carrick D, Haig C, Ahmed N, McEntegart M, Petrie MC, Eteiba H, et al. Myocardial hemorrhage after acute reperfused ST-segment–elevation myocardial infarction: relation to microvascular obstruction and prognostic significance. Circ Cardiovasc Imaging. 2016;9:e004148. ArticlePubMedPubMed Central Google Scholar
Konijnenberg LSF, Damman P, Duncker DJ, Kloner RA, Nijveldt R, van Geuns R-JM, et al. Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction. Cardiovasc Res. 2020;116:787–805. ArticleCASPubMed Google Scholar
Robbers LFHJ, Eerenberg ES, Teunissen PFA, Jansen MF, Hollander MR, Horrevoets AJG, et al. Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage. Eur Heart J. 2013;34:2346–53. ArticleCASPubMed Google Scholar
• de Waha S, Patel MR, Granger CB, Ohman EM, Maehara A, Eitel I, et al. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials. Eur Heart J. 2017;38:3502–10 Demonstrates the clinical significance of MVO following MI. Strong association with mortality and heart failure hospitalisation at one year. ArticlePubMedCAS Google Scholar
Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O’Brien SM, Boden WE, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382:1395–407. ArticlePubMedPubMed Central Google Scholar
Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality. Eur Heart J. 2012;33:2771–83. ArticlePubMedPubMed Central Google Scholar
Kleinbongard P, Böse D, Baars T, Möhlenkamp S, Konorza T, Schöner S, et al. Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation. Circ Res. 2011;108:344–52. ArticleCASPubMed Google Scholar
Heusch G. The coronary circulation as a target of cardioprotection. Circ Res. 2016;118:1643–58. ArticleCASPubMed Google Scholar
Heusch G. Coronary microvascular obstruction: the new frontier in cardioprotection. Basic Res Cardiol. 2019;114:45. ArticlePubMedCAS Google Scholar
Reffelmann T, Kloner RA. Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol. 2002;283:H1099–107. ArticleCASPubMed Google Scholar
Galiuto L. Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation. Heart. 2003;89:731–7. ArticleCASPubMedPubMed Central Google Scholar
Hombach V, Grebe O, Merkle N, Waldenmaier S, Hoher M, Kochs M, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J. 2005;26:549–57. ArticlePubMed Google Scholar
Carrick D, Haig C, Ahmed N, Rauhalammi S, Clerfond G, Carberry J, et al. Temporal evolution of myocardial hemorrhage and edema in patients after acute ST-segment elevation myocardial infarction: pathophysiological insights and clinical implications. J Am Heart Assoc. 2016;5:e002834. ArticlePubMedPubMed Central Google Scholar
• Maznyczka AM, Oldroyd KG, Greenwood JP, McCartney PJ, Cotton J, Lindsay M, et al. Comparative significance of invasive measures of microvascular injury in acute myocardial infarction. Circ Cardiovasc Interv. 2020;13:e008505. A contemporary, comprehensive overview of invasive physiological measurements and associations with MVO and clinical outcomes.
Sakuma T, Hayashi Y, Sumii K, Imazu M, Yamakido M. Prediction of short- and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization. J Am Coll Cardiol. 1998;32:890–7. ArticleCASPubMed Google Scholar
Hombach V, Merkle N, Kestler HA, Torzewski J, Kochs M, Marx N, et al. Characterization of patients with acute chest pain using cardiac magnetic resonance imaging. Clin Res Cardiol. 2008;97:760–7. ArticlePubMed Google Scholar
Guerra E, Hadamitzky M, Ndrepepa G, Bauer C, Ibrahim T, Ott I, et al. Microvascular obstruction in patients with non-ST-elevation myocardial infarction: a contrast-enhanced cardiac magnetic resonance study. Int J Card Imaging. 2014;30:1087–95. Article Google Scholar
Cochet A, Lalande A, Lorgis L, Zeller M, Beer J-C, Walker PM, et al. Prognostic value of microvascular damage determined by cardiac magnetic resonance in non ST-segment elevation myocardial infarction: comparison between first-pass and late gadolinium-enhanced images. Investig Radiol. 2010;45:725–32. Article Google Scholar
The TIMI study group. The thrombolysis in myocardial infarction (TIMI) trial. N Engl J Med. 1985;312:932–6.
Mehta RH, Harjai KJ, Cox D, Stone GW, Brodie B, Boura J, et al. Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol. 2003;42:1739–46. ArticlePubMed Google Scholar
Nijveldt R, Beek AM, Hirsch A, Stoel MG, Hofman MBM, Umans VAWM, et al. Functional recovery after acute myocardial infarction. J Am Coll Cardiol. 2008;52:181–9. ArticlePubMed Google Scholar
Husser O, Bodi V, Sanchis J, Nunez J, Lopez-Lereu MP, Monmeneu JV, et al. Predictors of cardiovascular magnetic resonance-derived microvascular obstruction on patient admission in STEMI. Int J Cardiol. 2013;166:77–84. ArticlePubMed Google Scholar
Carrick D, Haig C, Carberry J, May VTY, McCartney P, Welsh P, et al. Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction. JCI Insight. 2016;1:e85768. ArticlePubMedPubMed Central Google Scholar
van 't Hof AWJ, Liem A, Suryapranata H, JCA H, de Boer M-J, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation. 1998;97:2302–6. ArticlePubMed Google Scholar
Biesbroek PS, Roos ST, van Hout M, van der Gragt J, Teunissen PFA, de Waard GA, et al. Fluoroscopy assisted scoring of myocardial hypoperfusion (FLASH) ratio as a novel predictor of mortality after primary PCI in STEMI patients. Int J Cardiol. 2016;202:639–45. ArticlePubMed Google Scholar
Vicente J, Mewton N, Croisille P, Staat P, Bonnefoy-Cudraz E, Ovize M, et al. Comparison of the angiographic myocardial blush grade with delayed-enhanced cardiac magnetic resonance for the assessment of microvascular obstruction in acute myocardial infarctions. Catheter Cardiovasc Interv. 2009;74:1000–7. ArticleCASPubMed Google Scholar
Marra MP, Corbetti F, Cacciavillani L, Tarantini G, Ramondo AB, Napodano M, et al. Relationship between myocardial blush grades, staining, and severe microvascular damage after primary percutaneous coronary intervention. Am Heart J. 2010;159:1124–32. ArticlePubMed Google Scholar
Bertomeu-González V, Bodí V, Sanchis J, Núñez J, López-Lereu MP, Peña G, et al. Limitations of myocardial blush grade in the evaluation of myocardial perfusion in patients with acute myocardial infarction and TIMI grade 3 flow. Rev Esp Cardiol Engl Ed. 2006;59:575–81. Article Google Scholar
Ford TJ, Stanley B, Good R, Rocchiccioli P, McEntegart M, Watkins S, et al. Stratified medical therapy using invasive coronary function testing in angina. J Am Coll Cardiol. 2018;72:2841–55. ArticlePubMed Google Scholar
Friedman PL, Shook TL, Kirshenbaum JM, Selwyn AP, Ganz P. Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplasty. Circulation. 1986;74:330–9. ArticleCASPubMed Google Scholar
de Lemos JA. ST-segment resolution as a marker of epicardial and myocardial reperfusion after thrombolysis: insights from the TIMI 14 and in TIME-II trials. J Electrocardiol. 2000;33:67–72. ArticlePubMed Google Scholar
Dong J, Ndrepepa G, Schmitt C, Mehilli J, Schmieder S, Schwaiger M, et al. Early resolution of ST-segment elevation correlates with myocardial salvage assessed by Tc-99m sestamibi scintigraphy in patients with acute myocardial infarction after mechanical or thrombolytic reperfusion therapy. Circulation. 2002;105:2946–9. ArticlePubMed Google Scholar
Wong DTL, Leung MCH, Das R, Liew GYH, Teo KSL, Chew DP, et al. Intracoronary ECG during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction predicts microvascular obstruction and infarct size. Int J Cardiol. 2013;165:61–6. ArticlePubMed Google Scholar
Ng MKC, Yeung AC, Fearon WF. Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve. Circulation. 2006;113:2054–61. ArticlePubMed Google Scholar
Fearon WF, Low AF, Yong AS, McGeoch R, Berry C, Shah MG, et al. Prognostic value of the index of microcirculatory resistance measured after primary percutaneous coronary intervention. Circulation. 2013;127:2436–41. ArticlePubMedPubMed Central Google Scholar
McGeoch R, Watkins S, Berry C, Steedman T, Davie A, Byrne J, et al. The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2010;3:715–22. ArticlePubMed Google Scholar
Carrick D, Haig C, Ahmed N, Carberry J, Yue May VT, McEntegart M, et al. Comparative prognostic utility of indexes of microvascular function alone or in combination in patients with an acute ST-segment–elevation myocardial infarction. Circulation. 2016;134:1833–47. ArticlePubMedPubMed Central Google Scholar
De Maria GL, Alkhalil M, Wolfrum M, Fahrni G, Borlotti A, Gaughran L, et al. Index of microcirculatory resistance as a tool to characterize microvascular obstruction and to predict infarct size regression in patients with STEMI undergoing primary PCI. JACC Cardiovasc Imaging. 2019;12:837–48. ArticlePubMed Google Scholar
Teunissen PFA, de Waard GA, Hollander MR, Robbers LFHJ, Danad I, Biesbroek PS, et al. Doppler-derived intracoronary physiology indices predict the occurrence of microvascular injury and microvascular perfusion deficits after angiographically successful primary percutaneous coronary intervention. Circ Cardiovasc Interv. 2015;8:e001786. ArticlePubMed Google Scholar
Everaars H, de Waard GA, Driessen RS, Danad I, van de Ven PM, Raijmakers PG, et al. Doppler flow velocity and thermodilution to assess coronary flow reserve. JACC Cardiovasc Interv. 2018;11:2044–54. ArticlePubMed Google Scholar
Layland J, Carrick D, McEntegart M, Ahmed N, Payne A, McClure J, et al. Vasodilatory capacity of the coronary microcirculation is preserved in selected patients with non–ST-segment–elevation myocardial infarction. Circ Cardiovasc Interv. 2013;6:231–6. ArticlePubMed Google Scholar
Scarsini R, De Maria GL, Borlotti A, Kotronias RA, Langrish JP, Lucking AJ, et al. Incremental value of coronary microcirculation resistive reserve ratio in predicting the extent of myocardial infarction in patients with STEMI. Insights from the Oxford Acute Myocardial Infarction (OxAMI) Study. Cardiovasc Revasc Med. 2019;20:1148–55. ArticlePubMed Google Scholar
Maznyczka AM, Carrick D, Oldroyd KG, James-Rae G, McCartney P, Greenwood JP, et al. Thermodilution-derived temperature recovery time, a novel predictor of microvascular reperfusion and prognosis after myocardial infarction. EuroIntervention. 2020;e00904:19.
Nanto S, Masuyama T, Takano Y, Hori M, Nagata S. Determination of coronary zero flow pressure by analysis of the baseline pressure - flow relationship in humans. Jpn Circ J. 2001;65:793–6. ArticleCASPubMed Google Scholar
Patel N, Petraco R, Dall’Armellina E, Kassimis G, De Maria GL, Dawkins S, et al. Zero-flow pressure measured immediately after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction provides the best invasive index for predicting the extent of myocardial infarction at 6 months. JACC Cardiovasc Interv. 2015;8:1410–21. ArticlePubMed Google Scholar
Shimada K. Assessment of myocardial viability using coronary zero flow pressure after successful angioplasty in patients with acute anterior myocardial infarction. Heart. 2003;89:71–6. ArticleCASPubMedPubMed Central Google Scholar
The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med. 1983;309:331–6.
Ong P, Camici PG, Beltrame JF, Crea F, Shimokawa H, Sechtem U, et al. International standardization of diagnostic criteria for microvascular angina. Int J Cardiol. 2018;250:16–20. ArticlePubMed Google Scholar
Bière L, Donal E, Terrien G, Kervio G, Willoteaux S, Furber A, et al. Longitudinal strain is a marker of microvascular obstruction and infarct size in patients with acute ST-segment elevation myocardial infarction. PLoS One. 2014;9:e86959.
Huttin O, Zhang L, Lemarié J, Mandry D, Juillière Y, Lemoine S, et al. Global and regional myocardial deformation mechanics of microvascular obstruction in acute myocardial infarction: a three dimensional speckle-tracking imaging study. Int J Card Imaging. 2015;31:1337–46. Article Google Scholar
Luo AK, Wu KC. Imaging microvascular obstruction and its clinical significance following acute myocardial infarction. Heart Fail Rev. 2006;11:305–12. ArticlePubMed Google Scholar
Galiuto L, Garramone B, Scarà A, Rebuzzi AG, Crea F, La Torre G, et al. The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling. J Am Coll Cardiol. 2008;51:552–9. ArticlePubMed Google Scholar
Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P, Cerisano G, et al. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation. 2004;109:1121–6. ArticlePubMed Google Scholar
Wu KC, Kim RJ, Bluemke DA, Rochitte CE, Zerhouni EA, Becker LC, et al. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol. 1998;32:9. CAS Google Scholar
Berry C, Kellman P, Mancini C, Chen MY, Bandettini WP, Lowrey T, et al. Magnetic resonance imaging delineates the ischemic area at risk and myocardial salvage in patients with acute myocardial infarction. Circ Cardiovasc Imaging. 2010;3:527–35. ArticlePubMedPubMed Central Google Scholar
van Kranenburg M, Magro M, Thiele H, de Waha S, Eitel I, Cochet A, et al. Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC Cardiovasc Imaging. 2014;7:930–9. ArticlePubMed Google Scholar
Payne AR, Berry C, Kellman P, Anderson R, Hsu L-Y, Chen MY, et al. Bright-blood T 2 -weighted MRI has high diagnostic accuracy for myocardial hemorrhage in myocardial infarction: a preclinical validation study in swine. Circ Cardiovasc Imaging. 2011;4:738–45. ArticlePubMedPubMed Central Google Scholar
Nieman K, Shapiro MD, Ferencik M, Nomura CH, Abbara S, Hoffmann U, et al. Reperfused myocardial infarction: contrast-enhanced 64-section CT in comparison to MR imaging. Radiology. 2008;247:49–56. ArticlePubMed Google Scholar
Schofer J, Montz R, Mathey DG. Scintigraphic evidence of the “no reflow” phenomenon in human beings after coronary thrombolysis. J Am Coll Cardiol. 1985;5:593–8. ArticleCASPubMed Google Scholar
Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, et al. Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the working group on endothelins and endothelial factors of the European society of hypertensionã. J Hypertens. 2004;23:233–46. Article Google Scholar
De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, et al. Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation. Diabetes Care. 2013;36:1020–5. ArticlePubMedPubMed Central Google Scholar
Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy M-A, Simonson DC, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation. 1998;97:1695–701. ArticleCASPubMed Google Scholar
Singh K, Hibbert B, Singh B, Carson K, Premaratne M, Le May M, et al. Meta-analysis of admission hyperglycaemia in acute myocardial infarction patients treated with primary angioplasty: a cause or a marker of mortality? Eur Heart J Cardiovasc Pharmacother. 2015;1:220–8. ArticlePubMed Google Scholar
Eitel I, Hintze S, de Waha S, Fuernau G, Lurz P, Desch S, et al. Prognostic impact of hyperglycemia in nondiabetic and diabetic patients with ST-elevation myocardial infarction: insights from contrast-enhanced magnetic resonance imaging. Circ Cardiovasc Imaging. 2012;5:708–18. ArticlePubMed Google Scholar
Reinstadler SJ, Stiermaier T, Eitel C, Metzler B, de Waha S, Fuernau G, et al. Relationship between diabetes and ischaemic injury among patients with revascularized ST -elevation myocardial infarction. Diabetes Obes Metab. 2017;19:1706–13. ArticleCASPubMed Google Scholar
Ota S, Tanimoto T, Orii M, Hirata K, Shiono Y, Shimamura K, et al. Association between hyperglycemia at admission and microvascular obstruction in patients with ST-segment elevation myocardial infarction. J Cardiol. 2015;65:272–7. ArticlePubMed Google Scholar
Jensen CJ, Eberle HC, Nassenstein K, Schlosser T, Farazandeh M, Naber CK, et al. Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI. Clin Res Cardiol. 2011;100:649–59. ArticleCASPubMed Google Scholar
Dıaz R, Goyal A, Mehta SR, Afzal R, Xavier D, Pais P, et al. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA. 2007;298:2399–405. ArticlePubMed Google Scholar
Roos ST, Timmers L, Biesbroek PS, Nijveldt R, Kamp O, van Rossum AC, et al. No benefit of additional treatment with exenatide in patients with an acute myocardial infarction. Int J Cardiol. 2016;220:809–14. ArticlePubMed Google Scholar
Reinstadler SJ, Reindl M, Tiller C, Holzknecht M, Klug G, Metzler B. Obesity paradox in ST-elevation myocardial infarction: is it all about infarct size? Eur Heart J Qual Care Clin Outcomes. 2019;5:180–2. ArticlePubMed Google Scholar
Carrick D, Haig C, Maznyczka AM, Carberry J, Mangion K, Ahmed N, et al. Hypertension, microvascular pathology, and prognosis after an acute myocardial infarction. Hypertension. 2018;72:720–30. ArticleCASPubMed Google Scholar
Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13. Article Google Scholar
Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22–7.
Reinstadler SJ, Stiermaier T, Eitel C, Saad M, Metzler B, de Waha S, et al. Antecedent hypertension and myocardial injury in patients with reperfused ST-elevation myocardial infarction. J Cardiovasc Magn Reson. 2017;18:80. Article Google Scholar
Pedersen TR. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Atheroscler Suppl. 2004;5:81–7. ArticleCASPubMed Google Scholar
Cho KH, Jeong MH, Ahn Y, Kim YJ, Chae SC, Hong TJ, et al. Low-density lipoprotein cholesterol level in patients with acute myocardial infarction having percutaneous coronary intervention (the cholesterol paradox). Am J Cardiol. 2010;106:1061–8. ArticleCASPubMed Google Scholar
Oduncu V, Erkol A, Kurt M, Tanboğa İH, Karabay CY, Şengül C, et al. The prognostic value of very low admission LDL-cholesterol levels in ST-segment elevation myocardial infarction compared in statin-pretreated and statin-naive patients undergoing primary percutaneous coronary intervention. Int J Cardiol. 2013;167:458–63. ArticlePubMed Google Scholar
Golino P, Maroko PR, Carew TE. The effect of acute hypercholesterolemia on myocardial infarct size and the no-reflow phenomenon during coronary occlusion-reperfusion. Circulation. 1987;75:292–8. ArticleCASPubMed Google Scholar
Reindl M, Reinstadler SJ, Feistritzer H, Theurl M, Basic D, Eigler C, et al. Relation of lowdensity lipoprotein cholesterol with microvascular injury and clinical outcome in revascularized ST-elevation myocardial infarction. J Am Heart Assoc. 2017;6:e006957.
Iwakura K, Ito H, Kawano S, Okamura A, Kurotobi T, Date M, et al. Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction. Eur Heart J. 2006;27:534–9. ArticleCASPubMed Google Scholar
Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997;336:1276–82. ArticleCASPubMed Google Scholar
Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, Schäfers KP, Lüscher TF, Camici PG. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation. 2000;102:1233–8. ArticleCASPubMed Google Scholar
Symons R, Masci PG, Francone M, Claus P, Barison A, Carbone I, et al. Impact of active smoking on myocardial infarction severity in reperfused ST-segment elevation myocardial infarction patients: the smoker’s paradox revisited. Eur Heart J. 2016;37:2756–64. ArticlePubMed Google Scholar
Reinstadler SJ, Eitel C, Fuernau G, de Waha S, Desch S, Mende M, et al. Association of smoking with myocardial injury and clinical outcome in patients undergoing mechanical reperfusion for ST-elevation myocardial infarction. Eur Heart J Cardiovasc Imaging. 2017;18:39–45. ArticlePubMed Google Scholar
Fajar JK, Heriansyah T, Rohman MS. The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: a meta-analysis. Indian Heart J. 2018;70:S406–18. ArticlePubMedPubMed Central Google Scholar
Haig C, Carrick D, Carberry J, Mangion K, Maznyczka A, Wetherall K, et al. Current smoking and prognosis after acute ST-segment elevation myocardial infarction. JACC Cardiovasc Imaging. 2019;12:993–1003. ArticlePubMedPubMed Central Google Scholar
Claessen BEPM, Kikkert WJ, Engstrom AE, Hoebers LPC, Damman P, Vis MM, et al. Primary percutaneous coronary intervention for ST elevation myocardial infarction in octogenarians: trends and outcomes. Heart. 2010;96:843–7. ArticlePubMed Google Scholar
Kirma C, Izgi A, Dundar C, Tanalp AC, Oduncu V, Aung SM, et al. Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions. Circ J. 2008;72:716–21. ArticlePubMed Google Scholar
Ashraf T, Khan MN, Afaque SM, Aamir KF, Kumar M, Saghir T, et al. Clinical and procedural predictors and short-term survival of the patients with no reflow phenomenon after primary percutaneous coronary intervention. Int J Cardiol. 2019;294:27–31. ArticlePubMed Google Scholar
Kunadian V, Qiu W, Lagerqvist B, Johnston N, Sinclair H, Tan Y, et al. Gender differences in outcomes and predictors of all-cause mortality after percutaneous coronary intervention (data from United Kingdom and Sweden). Am J Cardiol. 2017;119:210–6. ArticlePubMed Google Scholar
Bavishi C, Bangalore S, Patel D, Chatterjee S, Trivedi V, Tamis-Holland JE. Short and long-term mortality in women and men undergoing primary angioplasty: a comprehensive meta-analysis. Int J Cardiol. 2015;198:123–30. ArticlePubMed Google Scholar
Cenko E, Yoon J, Kedev S, Stankovic G, Vasiljevic Z, Krljanac G, et al. Sex differences in outcomes after STEMI: effect modification by treatment strategy and age. JAMA Intern Med. 2018;178:632–9. ArticlePubMedPubMed Central Google Scholar
Bugiardini R, Ricci B, Cenko E, Vasiljevic Z, Kedev S, Davidovic G, et al. Delayed care and mortality among women and men with myocardial infarction. J Am Heart Assoc. 2017;6:e005968.
Vaccarino V, Badimon L, Corti R, de Wit C, Dorobantu M, Hall A, et al. Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors?: position paper from the working group on coronary pathophysiology and microcirculation of the European society of cardiology. Cardiovasc Res. 2011;90:9–17. ArticleCASPubMed Google Scholar
Maznyczka AM, Carrick D, Carberry J, Mangion K, McEntegart M, Petrie MC, et al. Sex-based associations with microvascular injury and outcomes after ST-segment elevation myocardial infarction. Open Heart. 2019;6:e000979. ArticlePubMedPubMed Central Google Scholar
Yoshino S, Cilluffo R, Best PJM, Atkinson EJ, Aoki T, Cunningham JM, et al. Single nucleotide polymorphisms associated with abnormal coronary microvascular function. Coron Artery Dis. 2014;25:281–9. ArticlePubMedPubMed Central Google Scholar
Husser O, Bodí V, Sanchis J, Núnez J, Mainar L, Rumiz E, et al. The sum of ST-segment elevation is the best predictor of microvascular obstruction in patients treated successfully by primary percutaneous coronary intervention. Cardiovascular magnetic resonance study. Rev Esp Cardiol Engl Ed. 2010;63:1145–54. Article Google Scholar
Appelbaum E, Kirtane AJ, Clark A, Pride YB, Gelfand EV, Harrigan CJ, et al. Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction. J Thromb Thrombolysis. 2009;27:123–9. ArticlePubMed Google Scholar
Nijveldt R, van der Vleuten PA, Hirsch A, Beek AM, Tio RA, Tijssen JGP, et al. Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size. JACC Cardiovasc Imaging. 2009;2:1187–94. ArticlePubMed Google Scholar
Weaver JC, Ramsay DD, Rees D, Binnekamp MF, Prasan AM, McCrohon JA. Dynamic changes in ST segment resolution after myocardial infarction and the association with microvascular injury on cardiac magnetic resonance imaging. Heart Lung Circ. 2011;20:111–8. ArticlePubMed Google Scholar
Maden O, Kaçmaz F, Selçuk MT, Selçuk H, Alyan Ö, Aksu T, et al. Relation of admission QRS duration with development of angiographic no-reflow in patients with acute ST-segment elevation myocardial infarction treated with primary percutaneous interventions. J Electrocardiol. 2008;41:72–7. ArticlePubMed Google Scholar
Selvester RH, Wagner GS. The Selvester QRS scoring system for estimating myocardial infarct size. Arch Intern Med. 1985;145:5. Article Google Scholar
Tiller C, Reindl M, Reinstadler SJ, Holzknecht M, Schreinlechner M, Peherstorfer A, et al. Complete versus simplified Selvester QRS score for infarct severity assessment in ST-elevation myocardial infarction. BMC Cardiovasc Disord. 2019;19:285. ArticlePubMedPubMed Central Google Scholar
Watanabe N, Isobe S, Okumura T, Mori H, Yamada T, Nishimura K, et al. Relationship between QRS score and microvascular obstruction after acute anterior myocardial infarction. J Cardiol. 2016;67:321–6. ArticlePubMed Google Scholar
Iwakura K, Ito H, Kawano S, Shintani Y, Yamamoto K, Kato A, et al. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol. 2001;38:472–7. ArticleCASPubMed Google Scholar
Park J, Choi KH, Lee JM, Kim HK, Hwang D, Rhee T, et al. Prognostic implications of door-to-balloon time and onset-to-door time on mortality in patients with ST-segment–elevation myocardial infarction treated with primary percutaneous coronary intervention. J Am Heart Assoc. 2019;8:e012188. PubMedPubMed Central Google Scholar
Kloner RA, Ganote CE, Jennings RB. The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54:1496–508. ArticleCASPubMedPubMed Central Google Scholar
Sdringola S, Assali AR, Ghani M, Moustapha A, Achour H, Yusuf SW, et al. Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous intervention. Catheter Cardiovasc Interv. 2001;54:318–24. ArticleCASPubMed Google Scholar
Jesel L, Morel O, Ohlmann P, Germain P, Faure A, Jahn C, et al. Role of pre-infarction angina and inflammatory status in the extent of microvascular obstruction detected by MRI in myocardial infarction patients treated by PCI. Int J Cardiol. 2007;121:139–47. ArticleCASPubMed Google Scholar
Nepper-Christensen L, Høfsten DE, Helqvist S, Lassen JF, Tilsted H-H, Holmvang L, et al. Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction. Heart. 2020;106:24–32. ArticleCASPubMed Google Scholar
Hausenloy DJ, Kharbanda RK, Møller UK, Ramlall M, Aarøe J, Butler R, et al. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial. Lancet. 2019;394:1415–24. ArticlePubMedPubMed Central Google Scholar
Feistritzer H-J, Reinstadler SJ, Klug G, Reindl M, Wöhrer S, Brenner C, et al. Multimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction: a prospective, observational study. BMC Cardiovasc Disord. 2016;16:239. ArticlePubMedPubMed CentralCAS Google Scholar
Pernet K, Ecarnot F, Chopard R, Seronde M-F, Plastaras P, Schiele F, et al. Microvascular obstruction assessed by 3-tesla magnetic resonance imaging in acute myocardial infarction is correlated with plasma troponin I levels. BMC Cardiovasc Disord. 2014;30:14–57.
Mayr A, Klug G, Schocke M, Trieb T, Mair J, Pedarnig K, et al. Late microvascular obstruction after acute myocardial infarction: relation with cardiac and inflammatory markers. Int J Cardiol. 2012;157:391–6. ArticlePubMed Google Scholar
Neizel M, Futterer S, Steen H, Giannitsis E, Reinhardt L, Lossnitzer D, et al. Predicting microvascular obstruction with cardiac troponin T after acute myocardial infarction: a correlative study with contrast-enhanced magnetic resonance imaging. Clin Res Cardiol. 2009;98:555–62. ArticleCASPubMed Google Scholar
Mather AN, Fairbairn TA, Artis NJ, Greenwood JP, Plein S. Relationship of cardiac biomarkers and reversible and irreversible myocardial injury following acute myocardial infarction as determined by cardiovascular magnetic resonance. Int J Cardiol. 2013;166:458–64. ArticlePubMed Google Scholar
Kim M-K, Chung W-Y, Cho Y-S, Choi S-I, Chae I-H, Choi D-J, et al. Serum N-terminal pro-B-type natriuretic peptide levels at the time of hospital admission predict of microvascular obstructions after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. J Interv Cardiol. 2011;24:34–41. ArticlePubMed Google Scholar
Magro M, Nauta S, Simsek C, Onuma Y, Garg S, van der Heide E, et al. Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: the MI SYNTAXscore study. Am Heart J. 2011;161:771–81. ArticlePubMed Google Scholar
Magro M, Nauta ST, Simsek C, Boersma E, van der Heide E, Regar E, et al. Usefulness of the SYNTAX score to predict “no reflow” in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am J Cardiol. 2012;109:601–6. ArticlePubMed Google Scholar
Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach. Chest. 2010;137:263–72. ArticlePubMed Google Scholar
Ipek G, Onuk T, Karatas MB, Gungor B, Osken A, Keskin M, et al. CHA 2 DS 2 -VASc score is a predictor of no-reflow in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous intervention. Angiology. 2016;67:840–5. ArticlePubMed Google Scholar
Stone GW, Selker HP, Thiele H, Patel MR, Udelson JE, Ohman EM, et al. Relationship between infarct size and outcomes following primary PCI. J Am Coll Cardiol. 2016;67:1674–83. ArticlePubMed Google Scholar
Ibanez B, Macaya C, Sánchez-Brunete V, Pizarro G, Fernández-Friera L, Mateos A, et al. Effect of early metoprolol on infarct size in ST-segment–elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial. Circulation. 2013;128:1495–503. ArticleCASPubMed Google Scholar
García-Prieto J, Villena-Gutiérrez R, Gómez M, Bernardo E, Pun-García A, García-Lunar I, et al. Neutrophil stunning by metoprolol reduces infarct size. Nat Commun. 2017;8:14780. ArticlePubMedPubMed CentralCAS Google Scholar
Roolvink V, Ibáñez B, Ottervanger JP, Pizarro G, van Royen N, Mateos A, et al. Early intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention. J Am Coll Cardiol. 2016;67:2705–15. ArticleCASPubMed Google Scholar
Jolicoeur EM, Dendukuri N, Belisle P, Range G, Souteyrand G, Bouisset F. Immediate vs. delayed stenting in ST-elevation myocardial infarction: rationale and design of the international PRIMACY Bayesian randomized controlled trial. Can J Cardiol. 2020;36:1805–14.
Sidik NP, McEntegart M, Roditi G, Ford TJ, McDermott M, Morrow A, et al. Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study. Am Heart J. 2020;221:48–59. ArticleCASPubMedPubMed Central Google Scholar